Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2020 Sep 30;408:115258. doi: 10.1016/j.taap.2020.115258

Fig. 6.

Fig. 6.

TCE exposure in MRL+/+ mice caused impairment in Nrf2 pathway, which was improved by SFN. Representative Western blot for Nrf2 (A) and HO-1 (B) in the spleens of MRL+/+ mice following treatment with TCE or TCE + SFN for 6 weeks. The data are presented as means ± SD (n = 6). * p < 0.05 vs. controls, # p < 0.05 vs. TCE-treated mice.